Savara announces ERS 2026 encore presentations of Phase 3 APAP results
Savara says it will present encore results from the Phase 3 clinical trial of molgramostim inhalation solution in autoimmune pulmonary alveolar proteinosis at the European Respiratory Society Congress 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.